title: [Adalimumab therapy for Vogt-Koyanagi-Harada syndrome].
authors.forename: M
authors.initials: M
authors.lastname: Díaz Llopis
authors.forename: L
authors.initials: L
authors.lastname: Amselem
authors.forename: F J
authors.initials: FJ
authors.lastname: Romero
authors.forename: S
authors.initials: S
authors.lastname: García-Delpech
authors.forename: M L
authors.initials: ML
authors.lastname: Hernández
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D013997:Time Factors; D016896:Treatment Outcome; D014607:Uveomeningoencephalitic Syndrome / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab